Evidence map›Paper›PMID 36212510›Full record

ArticleCardiology and cardiovascular medicine2022

Impact of Contrast-Induced Nephropathy on Long-Term Renal Function after Coronary Angiography and Contrast-Enhanced Computed Tomography.

Hidekazu Moriya, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Mizuki Yamano, Hiroyuki Suzuki, Takayasu Ohtake, Sumi Hidaka, Shuzo Kobayashi

Open access · hybridAbstract read
In one paragraph

Article in Cardiology and cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hidekazu MoriyaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Yasuhiro MochidaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Kunihiro IshiokaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Machiko OkaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Kyoko MaesatoKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Mizuki YamanoKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Hiroyuki SuzukiKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Takayasu OhtakeKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Sumi HidakaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Shuzo KobayashiKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Shonan Kamakura General Hospital · JP

Funding

Novel Approach to Stabilize Atherosclerotic Plaque in Carotid ArteryR01HL144125 · NHLBI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI AGRAWAL, DEVENDRA K. · 2018 to 2021
$2.8M
NHLBI NIH HHS R01 HL144125
6 · The paper itself

Abstract

Background: It remains unclear whether contrast-induced nephropathy (CIN) has a prognostic impact on subsequent renal dysfunction and whether deteriorating renal function is a risk factor for CIN. This study aimed to evaluate the occurrence of CIN in patients with pre-existing renal dysfunction and investigate the long-term effects of worsening renal function after coronary angiography or contrast-enhanced computed tomography (CT). The prognostic factors of worsening renal dysfunction were also analyzed. Methods: This was a prospective cohort study of patients at risk for CIN, defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m Results: Of the 410 patients, 19 patients developed CIN (8/142 patients on coronary angiography and 11/268 patients on contrast-enhanced CT), and 38 patients had worsened renal function (21/142 patients on coronary angiography and 17/268 patients on contrast-enhanced CT). CIN was not associated with worsening renal function at 2 years. Analysis by renal function at the time of coronary angiography or contrast-enhanced CT (i.e., eGFR ≥30 ml/min/1.73 m Conclusions: CIN is not a prognostic risk factor for the long-term of chronic kidney disease after coronary angiography or contrast-enhanced CT. Pre-existing renal dysfunction is also not a risk factor for CIN, even if the eGFR is <30 ml/min/1.73 m

Indexed as

Chronic Kidney DiseaseContrast-Induced NephropathyContrast MediaPrognosis

Identifiers

PMID36212510
PMCPMC9536241
OpenAlexW4304117866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.